Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

ClinicalTrials.gov ID: NCT05995405

Public ClinicalTrials.gov record NCT05995405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 4:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective, Randomized Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to deliver nimodipine via IV directly into the bloodstream and to determine if this is as safe and tolerable as oral nimodipine capsules.

Study identification

NCT ID
NCT05995405
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Grace Therapeutics Inc.
Industry
Enrollment
100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2023
Primary completion
Nov 30, 2024
Completion
Nov 30, 2024
Last update posted
Sep 30, 2024

2023 – 2024

United States locations

U.S. sites
22
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
The University of Alabama at Birmingham Birmingham Alabama 35233 —
Brain and Spine Neurological Institute Phoenix Arizona 85013 —
Community Regional Medical Center Fresno California 93701 —
Mayo Clinic Florida Jacksonville Florida 32224 —
Emory University School of Medicine Emergency Neurosciences Atlanta Georgia 30303 —
Northwestern Feinberg Pavillion Neuro and Spine ICU Chicago Illinois 60611 —
Indiana University Health Methodist Hospital Indianapolis Indiana 46202 —
University of Kentucky Hospital Lexington Kentucky 40536 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Washington University St Louis Missouri 63110 —
The Mount Sinai Hospital New York New York 10029 —
University of North Carolina Chapel Hill North Carolina 27599 —
Duke University Durham North Carolina 27710 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
Oregon Health and Science University Portland Oregon 97239 —
Methodist University Hospital Memphis Tennessee 38104 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
University of Texas Health Science Center at Houston Houston Texas 77030 —
Virginia Commonwealth University Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05995405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2024 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05995405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →